Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

Authors of this article:

André Luiz Schuh Teixeira da Rosa^{1, 2} ;   Marina Ribeiro Barreto da Costa^{1, 2} ;   Gabriela Bezerra Sorato^{2, 3} ;   Felipe de Moura Manjabosco^{2, 3} ;   Érica Bonganhi de Bem^{1, 2} ;   Lucas Dellazari² ;   Arthur Bezerra Falcão^{1, 2} ;   Lucas de Oliveira Cia^{2, 3} ;   Olivia Sorato Bezerra⁴ ;   Rogério Boff Borges^{5, 6} ;   Luis Augusto Rohde^{7, 8, 9, 10} ;   Ana Soledade Graeff-Martins^{1, 2}